and (3) reported performance metrics of safety and/or efficacy (e.g., assessment of effectiveness in tumor response, pain response, tumor volume reduction, adverse events (AEs))
doi: 10.1111/imj.16388 44 LiYTanYXiaGShuaiJ
This is particularly important in the context of brain injury, where cellular health is critical to recovery and function
Therefore, there is a pressing need to improve the persistence, specificity, and safety of CAR T cell therapy to overcome these challenges and enhance its therapeutic potential
oleifera defatted seed extract and a coagulant protein (measuring 5000 mg/kg
At twice-weekly dosing, the vial would last 10 weeks exceeding the stability window